Company Search:
Advanced Search
Sponsored Links
Dar Al Dawa Development & Investment Company Snapshot
Dar Al Dawa Development & Investment operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dar Al Dawa Development & Investment with three other pharmaceutical manufacturers in Middle East: Enzymotec Ltd of Israel (2016 sales of 182.39 million Israel Shekels [US$52.78 million] of which 104% was Nutrition), Egypt International Pharmaceuticals of Egypt (1.97 billion Egyptian Pounds [US$112.00 million] of which 100% was Pharmaceutical), and Glaxo Smith Kline which is also based in Egypt (1.17 billion Egyptian Pounds [US$66.30 million] of which 93% was Medical Sector).

Sales Analysis. Dar Al Dawa Development & Investment reported sales of 60.88 million Jordanian Dinars (US$85.86 million) for the year ending December of 2016. This represents a decrease of 2.0% versus 2015, when the company's sales were 62.14 million Jordanian Dinars. Contributing to the drop in overall sales was the 9.6% decline in Infant Food and Milk, from 13.56 million Jordanian Dinars to 12.26 million Jordanian Dinars. . However, these declines were partially offset by the increase in sales of Pharmaceuticals (up 0.1% to 48.61 million Jordanian Dinars) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dar Al Dawa Development & Investment
  Stock Performance Chart for Dar Al Dawa Development & Investment
  Stock Data: Recent Stock Performance:
  Current Price (3/15/2018): 1.52
(Figures in Jordanian Dinars)
1 Week 3.4%   13 Weeks -9.0%  
4 Weeks -20.4%   52 Weeks -30.9%  
Dar Al Dawa Development & Investment Key Data:
  Ticker: DADI Country: Jordan
  Exchanges: AMN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 60,876,997
(Year Ending Jan 2017).
Employees: 1,103
  Currency: Jordanian Dinars Market Cap: 38,000,000
  Fiscal Yr Ends: December Shares Outstanding: 25,000,000
  Share Type: Ordinary Closely Held Shares: 13,288,250
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.